Apple Watch launched in 2015 as a luxury wearable with modest health features: heart rate monitoring, basic activity tracking. A decade later it's the best-selling smartwatch globally, with health features now central to its value proposition. ECG capability, blood oxygen monitoring, fall detection, and irregular rhythm notifications evolved from novelty into standard expectations. The Verge's Victoria Song frames this arc as definitional for the entire health tech category.

But the real story is economic. Apple sold 40+ million watches in 2023 alone, generating recurring revenue through hardware upgrades, cellular subscriptions, and integration lock-in with the iPhone ecosystem. The watch became a Trojan horse for health data collection. Every pulse, every fall, every stress spike flows into Apple's servers, creating detailed phenotypic profiles of 100+ million wearers. That data is now foundational to Apple's health services play, including partnerships with insurers and healthcare providers. The watch didn't define modern health tech through innovation alone. It defined it by proving health monitoring could be mass-market, profitable, and sticky.

The Apple Watch established the playbook that every health tech company now follows: build a consumer device with real-time biometric capture, embed it into daily behavior, create switching costs through ecosystem lock-in, monetize the data through services and partnerships. Competitors from Fitbit (acquired by Google for $2.1 billion) to Oura to Whoop mimicked the model. The FDA now certifies smartwatch features as medical devices. Insurance companies offer discounts for wearing them. This is health surveillance rebranded as wellness.

The second-order effect is regulatory vulnerability. Once health watches become ubiquitous and insurance-linked, governments will demand oversight. The EU's Digital Health regulations are already tightening. The US FDA is moving toward stricter oversight of health claims. Apple's dominance here means it will shape regulation by default. A company that spent two decades avoiding privacy scrutiny in software is now collecting more intimate data about human bodies than any hardware maker in history. Song's piece sidesteps this entirely, celebrating the utility without naming the consolidation risk.

Apple wins decisively. The watch is a margin multiplier and ecosystem lock-in device that generates services revenue for a decade per customer. Google wins with Fitbit ownership and Android health integration, though execution remains scattered. Samsung and Garmin survive but shrink. Healthcare incumbents lose pricing power as Apple extracts value upstream. Patients win short-term convenience but lose long-term data sovereignty. Insurance companies win access to behavioral data at scale. Privacy advocates lose ground with each health feature announced.

Watch for Apple launching direct-to-consumer health services (lab testing, telehealth, insurance products) in 2025-2026 using the watch as the enrollment device. Monitor FDA decisions on watch-derived health claims. Track whether EU regulations force Apple to open health data APIs to competitors. Measure insurance company premium adjustments based on watch data.